Insulin and IGF have been shown to accelerate the growth of endometrial cancer cells in vitro, and the mitogenic effect of hyperinsulinemia may be mediated by activation of the mitogen-activated protein kinase (MAPK) pathway [170], increasing expression of vascular endothelial growth factor (VEGF) [171]. The gene discussed is VEGFA; the disease is Hyperinsulinemia.